238 related articles for article (PubMed ID: 26880832)
1. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis.
Ziemek J; Man A; Hinchcliff M; Varga J; Simms RW; Lafyatis R
Rheumatology (Oxford); 2016 May; 55(5):911-7. PubMed ID: 26880832
[TBL] [Abstract][Full Text] [Related]
2. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis.
Kissin EY; Merkel PA; Lafyatis R
Arthritis Rheum; 2006 Nov; 54(11):3655-60. PubMed ID: 17075814
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 9 in systemic sclerosis patients: relation to modified Rodnan skin score, disease severity, and functional status.
Gheita TA; Sayed S; Azkalany GS; Abaza N; Hammam N; Eissa AH
Clin Rheumatol; 2018 Mar; 37(3):757-763. PubMed ID: 29076114
[TBL] [Abstract][Full Text] [Related]
4. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire.
Temiz Karadag D; Karakas F; Tekeoglu S; Yazici A; Isik OO; Cefle A
Clin Rheumatol; 2019 Jul; 38(7):1917-1923. PubMed ID: 30840212
[TBL] [Abstract][Full Text] [Related]
5. High-throughput quantitative histology in systemic sclerosis skin disease using computer vision.
Correia C; Mawe S; Lofgren S; Marangoni RG; Lee J; Saber R; Aren K; Cheng M; Teaw S; Hoffmann A; Goldberg I; Cowper SE; Khatri P; Hinchcliff M; Mahoney JM
Arthritis Res Ther; 2020 Mar; 22(1):48. PubMed ID: 32171325
[TBL] [Abstract][Full Text] [Related]
6. The correlation between durometer score and modified Rodnan skin score in systemic sclerosis.
Moon KW; Song R; Kim JH; Lee EY; Lee EB; Song YW
Rheumatol Int; 2012 Aug; 32(8):2465-70. PubMed ID: 21769489
[TBL] [Abstract][Full Text] [Related]
7. Association of C-reactive protein with high disease activity in systemic sclerosis: results from the Canadian Scleroderma Research Group.
Muangchan C; Harding S; Khimdas S; Bonner A; ; Baron M; Pope J
Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1405-14. PubMed ID: 22556030
[TBL] [Abstract][Full Text] [Related]
8. Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey.
Rannou F; Poiraudeau S; Berezné A; Baubet T; Le-Guern V; Cabane J; Guillevin L; Revel M; Fermanian J; Mouthon L
Arthritis Rheum; 2007 Feb; 57(1):94-102. PubMed ID: 17266096
[TBL] [Abstract][Full Text] [Related]
9. Cross-cultural adaptation and validation of the Brazilian version of the Scleroderma Health Assessment Questionnaire (SHAQ).
Rocha LF; Marangoni RG; Sampaio-Barros PD; Levy-Neto M; Yoshinari NH; Bonfa E; Steen V; Kowalski SC
Clin Rheumatol; 2014 May; 33(5):699-706. PubMed ID: 23975361
[TBL] [Abstract][Full Text] [Related]
10. Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II).
Khanna D; Clements PJ; Volkmann ER; Wilhalme H; Tseng CH; Furst DE; Roth MD; Distler O; Tashkin DP
Arthritis Res Ther; 2019 Jan; 21(1):23. PubMed ID: 30651141
[TBL] [Abstract][Full Text] [Related]
11. Scleroderma lung study (SLS): differences in the presentation and course of patients with limited versus diffuse systemic sclerosis.
Clements PJ; Roth MD; Elashoff R; Tashkin DP; Goldin J; Silver RM; Sterz M; Seibold JR; Schraufnagel D; Simms RW; Bolster M; Wise RA; Steen V; Mayes MD; Connelly K; Metersky M; Furst DE;
Ann Rheum Dis; 2007 Dec; 66(12):1641-7. PubMed ID: 17485423
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Portuguese Version of the Scleroderma Health Assessment Questionnaire.
Genrinho I; Ferreira PL; Santiago T; Carones A; Mazeda C; Barcelos A; Beirão T; Costa F; Santos I; Couto M; Rato M; Terroso G; Monteiro P
Int J Environ Res Public Health; 2023 Nov; 20(22):. PubMed ID: 37998293
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of European Scleroderma Group Activity Index in an early scleroderma cohort.
Nevskaya T; Baron M; Pope JE;
Rheumatology (Oxford); 2017 Jul; 56(7):1111-1122. PubMed ID: 28340090
[TBL] [Abstract][Full Text] [Related]
14. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
Hanitsch LG; Burmester GR; Witt C; Hunzelmann N; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Schulze-Lohoff E; Becker M; Sunderkoetter C; ; Riemekasten G
Rheumatology (Oxford); 2009 Jan; 48(1):70-3. PubMed ID: 19056798
[TBL] [Abstract][Full Text] [Related]
15. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.
Furst DE; Clements PJ; Steen VD; Medsger TA; Masi AT; D'Angelo WA; Lachenbruch PA; Grau RG; Seibold JR
J Rheumatol; 1998 Jan; 25(1):84-8. PubMed ID: 9458208
[TBL] [Abstract][Full Text] [Related]
16. Changes in disability and their relationship with skin thickening, in diffuse and limited cutaneous systemic sclerosis: a retrospective cohort study.
Peytrignet S; Manning J; Wragg E; Moore T; Samaranayaka M; Dinsdale G; Herrick AL
Scand J Rheumatol; 2019 May; 48(3):230-234. PubMed ID: 30394164
[TBL] [Abstract][Full Text] [Related]
17. Ventricular late potentials in systemic sclerosis: relationship with skin involvement.
Paradiso M; Di Franco M; Musca A; Basili S; Riccieri V; Paoletti V; De Matteis A; Mammarella A
J Rheumatol; 2002 Jul; 29(7):1388-92. PubMed ID: 12136893
[TBL] [Abstract][Full Text] [Related]
18. Validation of French version of the Scleroderma Health Assessment Questionnaire (SSc HAQ).
Georges C; Chassany O; Mouthon L; Tiev K; Toledano C; Meyer O; Marjanovic Z; Heneggar C; Papo T; Crickx B; Sereni D; Cabane J; Farge D
Clin Rheumatol; 2005 Feb; 24(1):3-10. PubMed ID: 15674652
[TBL] [Abstract][Full Text] [Related]
19. Association of metabolites reflecting type III and VI collagen formation with modified Rodnan skin score in systemic sclerosis - a cross-sectional study.
Juhl P; Vinderslev Iversen L; Karlsmark T; Asser Karsdal M; Bay-Jensen AC; Mogensen M; Siebuhr AS
Biomarkers; 2019 Jun; 24(4):373-378. PubMed ID: 30821519
[No Abstract] [Full Text] [Related]
20. Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis.
Malcarne VL; Hansdottir I; McKinney A; Upchurch R; Greenbergs HL; Henstorf GH; Furst DE; Clements PJ; Weisman MH
J Rheumatol; 2007 Feb; 34(2):359-67. PubMed ID: 17304659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
